The Pharmaceuticals in Dosage market in Austria has seen a fluctuating trend from 2012 to 2022, with values per capita in thousand US dollars showing growth and contraction at various intervals. The market experienced a notable dip in 2015, followed by a gradual recovery and significant fluctuations in the following years. For instance, there was a decline from 1.17 in 2014 to 0.9311 in 2017, followed by an increase to 1.17 by 2021. The value slightly decreased to 1.07 in 2022.
In terms of recent variations, from 2021 to 2022, there was a slight decline of approximately 8.55%. However, the compound annual growth rate (CAGR) over the last five years (2017-2022) stands at about 1.22%, indicating a modest overall upward trend. As of 2023, the market is observed to have continued in this trajectory.
Future trends to watch for include advancements in pharmaceutical technologies, changes in healthcare policies, potential impacts of economic factors on healthcare spending, and demographic shifts. Monitoring these factors will be crucial for understanding the potential trajectory of the Pharmaceuticals in Dosage market size value per capita in Austria.
How does Austria rank in Pharmaceuticals in Dosage Market Size Value Per Capita?
| # | 59 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 1,580 | 2023 | View data | ||
| 2 | 2 Germany | 1,460 | 2023 | View data | ||
| 3 | 3 Denmark | 1,300 | 2023 | View data | ||
| 4 | 4 Iceland | 1,220 | 2023 | View data | ||
| 5 | 5 Norway | 1,070 | 2023 | View data | ||
| 6 | 6 France | 1,030 | 2023 | View data | ||
| 7 | 7 Austria | 1,010 | 2023 | |||
| 8 | 8 Israel | 990.06 | 2023 | View data | ||
| 9 | 9 United Kingdom | 969.43 | 2023 | View data | ||
